✓ Translated by DotMD AI Clinical Council Source: Acta diabetologica • Randomized Controlled Trial
Verify Primary Source: NIH PubMed PMID #32020414 ↗

Randomized Controlled Trial: Exercise improves metformin 72-h glucose control by reducing the frequency of hyperglycemic peaks (N = 16)

Original Paper Title: “Exercise improves metformin 72-h glucose control by reducing the frequency of hyperglycemic peaks”

Elena Rostova (AI Quant) Rigor Score
88 / 100
Sample Size (Participants)
N = 16
Evidence Classification
Randomized Controlled Trial
Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways
  • Intense aerobic exercise in patients with diabetes and prediabetes under metformin treatment reduces free-living 72-h blood hyperglycemic peaks. This may help to prevent the development of cardiovascular complications associated with diabetes.
  • Study Design & Sample: Randomized Controlled Trial published in Acta diabetologica (N = 16 human participants).
  • Biostatistical Rigor Score: 88/100 audited by Elena Rostova (AI Biostatistician & openFDA Quant).

What the Study Found (In Plain English)

Published in Acta diabetologica (2020), this randomized controlled trial evaluating 16 human participants investigated: To determine the separated and combined effects of metformin and exercise on insulin sensitivity and free-living glycemic control in overweight individuals with prediabetes/type 2 diabetes (T2DM). Key clinical takeaway: Intense aerobic exercise in patients with diabetes and prediabetes under metformin treatment reduces free-living 72-h blood hyperglycemic peaks. This may help to prevent the development of cardiovascular complications associated with diabetes.

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Primary Endpoint & Quantitative Summary (Acta diabetologica, 2020-06-15; N = 16; Rigor 88/100): Intense aerobic exercise in patients with diabetes and prediabetes under metformin treatment reduces free-living 72-h blood hyperglycemic peaks. This may help to prevent the development of cardiovascular complications associated with diabetes.

Study Limitations & Caveats Before You Act

Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Randomized Controlled Trial). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.

Related DotMD Clinical Hubs & Price Ledgers

Rx: metformin-hcl → Rx: metformin-hydrochloride → Rx: glucose-and-sodium-chloride-dextrose-anhydrous-and-sodium-chloride → Rx: sugar-control-morus-alba-leaf → Condition: blood-glucose → Condition: diabetes →
Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 32020414: Randomized Controlled Trial: Exercise improves metformin 72-h glucose control by reducing the frequency of hyperglycemic peaks (N = 16)

3 of 3 Free Questions Remaining